SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Research Store
Biotech Bay
Datamonitor Report: American Academy of Neurology 2010: New Treatments Address Unmet Needs In Alzheimer’s And Epilepsy
April 23, 2010
 · 
5 min read
Lone Star Bio
Chemotherapy Plus Synthetic Compound Provides Potent Anti-Tumor Effect in Pancreatic Cancers, UT Southwestern Medical Center Study
April 21, 2010
 · 
1 min read
Lone Star Bio
Well-Done Meat Doubles Bladder Cancer Risk, University of Texas Study
April 20, 2010
 · 
1 min read
Lone Star Bio
Narcolepsy Drug Fixes FM Sleep Symptoms, University of Texas Medical School Study
April 20, 2010
 · 
1 min read
Lone Star Bio
Doctors At Texas Children’s Cancer Centre Lengthen 9-Yr-Old Girl’s Leg Magnetically
April 19, 2010
 · 
1 min read
Lone Star Bio
Scientists Find New Genes for Cancer, Other Diseases in Plants, Yeast and Worms, University of Texas Study
April 19, 2010
 · 
1 min read
Lone Star Bio
Testing Lung Tumors Tailors Chemotherapy, University of Texas MD Anderson Cancer Center Study
April 19, 2010
 · 
1 min read
Lone Star Bio
Diet High in B-Vitamins Lowers Heart Risks in Japanese Study Reported in Stroke: Journal of the American Heart Association
April 16, 2010
 · 
1 min read
Lone Star Bio
Gene Identified for Sudden Unexpected Death in Epilepsy, Baylor College of Medicine Study
April 14, 2010
 · 
1 min read
Lone Star Bio
Chip Checks For Oral Cancer, Rice University, University of Texas Health Science Center And University of Texas MD Anderson Cancer Center Study
April 6, 2010
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Natera and Aveta Biomics Announce Strategic Partnership Supporting Global Phase 3 Registrational Trial of APG-157 in Head and Neck Cancer
June 29, 2026
 · 
6 min read
Press Releases
Decoy Therapeutics, Inc. Announces Up to $21 Million Private Placement Financing
June 28, 2026
 · 
5 min read
Press Releases
FibroBiologics Announces up to $9.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
June 26, 2026
 · 
6 min read
Press Releases
Medicenna Therapeutics Reports Fiscal Year 2026 Financial Results and Operational Highlights
June 26, 2026
 · 
11 min read
Press Releases
DecisionDx®-Melanoma’s i31-SLNB Outperforms MIA Nomogram in Identifying Patients Who May Safely Forgo Sentinel Lymph Node Biopsy
June 25, 2026
 · 
10 min read
Press Releases
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
June 25, 2026
 · 
7 min read
Press Releases
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026
 · 
3 min read
Press Releases
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 25, 2026
 · 
5 min read
Press Releases
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
June 24, 2026
 · 
5 min read
Load More